Picture of Corcept Therapeutics Incorporated logo

CORT — Corcept Therapeutics Incorporated News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Corcept Therapeutics Q1 EPS USD 0.25 Vs. IBES Estimate USD 0.22

May 01 (Reuters) - Corcept Therapeutics Q1 net income USD 27.762 million vs.
IBES estimate USD 25.3 million.
* Q1 revenue USD 146.808 million vs. IBES estimate USD 141.2 million
* Q1 cash & investments USD 451 million
* outlook FY revenue USD 620-650 million

Recent news on Corcept Therapeutics Incorporated

See all news